Literature DB >> 26235469

Preoperative epidural injections are associated with increased risk of infection after single-level lumbar decompression.

Scott Yang1, Brian C Werner1, Jourdan M Cancienne1, Hamid Hassanzadeh1, Adam L Shimer1, Francis H Shen1, Anuj Singla2.   

Abstract

BACKGROUND CONTEXT: Lumbar epidural steroid injections (LESIs) are often performed as a treatment option for lumbar stenosis and radiculopathy before lumbar decompression surgery. Several case series have reported spinal infections after LESIs. There is lack of literature on the rate of postoperative infections after lumbar decompression in patients who had prior LESIs.
PURPOSE: The goal of the present study is to employ a large national database to determine if there is an association between preoperative LESIs at various time intervals before lumbar decompression and the incidence of postoperative infection. STUDY DESIGN/
SETTING: Retrospective case control database study, Level III was used in this study. PATIENT SAMPLE: This study comprised Medicare patients over age 65 years who had a LESI within 1 year of single-level lumbar decompression surgery. OUTCOME MEASURES: International Classification of Diseases, 9th Revision diagnosis codes for postoperative infection and Current Procedural Terminology procedure codes for treatment of postoperative infection were the outcome measures for this study.
METHODS: The PearlDiver Patient Records Database, an insurance-based database of patient records, was used for this study. The database was queried for LESI and single-level lumbar decompression procedures using Current Procedural Terminology codes. These study patients were then divided into four separate cohorts: (1) lumbar decompression within 1 month following LESI, (2) lumbar decompression between 1 and 3 months following LESI, (3) lumbar decompression between 3 and 6 months following LESI, and (4) lumbar decompression between 6 and 12 months following LESI. Unique control groups for each study cohort were created with patients who underwent single-level lumbar decompression without previous LESI and matched for major risk factors for infection, including age, gender, smoking status, diabetes, and obesity.
RESULTS: Overall, the rate of postoperative infection after single-level lumbar decompression after LESI remained relatively low, ranging between 0.8% and 1.7%. The incidence of 90-day postoperative infection after lumbar decompression was significantly higher than matched controls in groups with LESI within 1 month (OR=3.2, p<.0001) and 1-3 months before surgery (OR=1.8, p<.0001). The incidence of 90-day postoperative infection was not significantly different from matched controls in groups with LESI between 3-6 months (OR=1.3, p=.15) and 6-12 months before decompression surgery (OR=1.3, p=.18)
CONCLUSIONS: Single-level lumbar decompression within 3 months after LESI may be associated with an increased rate of postoperative infection. Increasing the time interval between LESI and single-level lumbar decompression surgery to at least 3 months may decrease postoperative infection rates.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Epidural injection; Lumbar decompression; Postoperative infection; Spinal infection; Spine surgery

Mesh:

Year:  2015        PMID: 26235469     DOI: 10.1016/j.spinee.2015.07.439

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  10 in total

1.  Early postoperative fluoroquinolone use is associated with an increased revision rate after arthroscopic rotator cuff repair.

Authors:  Jourdan M Cancienne; Stephen F Brockmeier; Scott A Rodeo; Chris Young; Brian C Werner
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-10-13       Impact factor: 4.342

2.  Infection Risk of Lumbar Epidural Injection in the Operating Theatre Prior to Lumbar Fusion Surgery.

Authors:  Peng Li; Xiuwei Hou; Lifeng Gao; Xiaochen Zheng
Journal:  J Pain Res       Date:  2020-08-26       Impact factor: 3.133

3.  An epidural steroid injection in the 6 months preceding a lumbar decompression without fusion predisposes patients to post-operative infections.

Authors:  Chester J Donnally; Augustus J Rush; Sebastian Rivera; Rushabh M Vakharia; Ajit M Vakharia; Dustin H Massel; Frank J Eismont
Journal:  J Spine Surg       Date:  2018-09

4.  Neurological complications of lumbar and cervical dural punctures with a focus on epidural injections.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2017-04-26

5.  Pain Management During COVID-19 and Steroids: Striking a Balance.

Authors:  Steven P Cohen; W Michael Hooten; Christopher R Phillips
Journal:  Pain Med       Date:  2020-08-01       Impact factor: 3.750

6.  Surgical Site Infection in Spine Surgery: Who Is at Risk?

Authors:  Reina Yao; Hanbing Zhou; Theodore J Choma; Brian K Kwon; John Street
Journal:  Global Spine J       Date:  2018-12-13

7.  Recent Preoperative Lumbar Epidural Steroid Injection Is an Independent Risk Factor for Incidental Durotomy During Lumbar Discectomy.

Authors:  Lawal A Labaran; Varun Puvanesarajah; Sandesh S Rao; Dennis Chen; Francis H Shen; Amit Jain; Hamid Hassanzadeh
Journal:  Global Spine J       Date:  2019-03-21

8.  The Impact of Corticosteroid Injection Timing on Infection Rates Following Spine Surgery: A Systematic Review and Meta-Analysis.

Authors:  Gregory S Kazarian; Michael E Steinhaus; Han Jo Kim
Journal:  Global Spine J       Date:  2021-09-26

9.  Implant Removal and Spacer Placement for Infected Shoulder Arthroplasty: Risk Factors for Repeat Procedures, Spacer Retention, and Mortality.

Authors:  J M Cancienne; Stephen F Brockmeier; James C Carr; Brian C Werner
Journal:  HSS J       Date:  2017-11-27

10.  Epidural Steroid Injections for Management of Degenerative Spondylolisthesis: Little Effect on Clinical Outcomes in Operatively and Nonoperatively Treated Patients.

Authors:  Michael C Gerling; Cole Bortz; Katherine E Pierce; Jon D Lurie; Wenyan Zhao; Peter G Passias
Journal:  J Bone Joint Surg Am       Date:  2020-08-05       Impact factor: 6.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.